Inspira Technologies Enhances INSPIRA ART100 Device

Ticker: IINNW · Form: 6-K · Filed: Jan 27, 2025 · CIK: 1837493

Sentiment: neutral

Topics: product-update, medical-devices, press-release

TL;DR

Inspira Tech just dropped new features for their ART100 device, aiming for better user and system support.

AI Summary

On January 27, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced advancements for its INSPIRA ART100 device. These new features aim to enhance user and system support, building upon the existing capabilities of their surgical technology.

Why It Matters

These upgrades to the INSPIRA ART100 could improve surgical outcomes and operational efficiency for healthcare providers using the technology.

Risk Assessment

Risk Level: low — This filing is a routine report of foreign private issuer and does not contain significant financial or strategic changes.

Key Players & Entities

FAQ

What specific advanced features were introduced for the INSPIRA ART100?

The filing states that advanced features were introduced for the INSPIRA ART100, but the specific details of these features are not provided in this Form 6-K, which refers to an attached press release (Exhibit 99.1) for further information.

What is the primary purpose of the new features for the INSPIRA ART100?

The new features are intended to further amplify user and system support for the INSPIRA ART100 device.

When was the press release announcing these advancements issued?

The press release announcing the advancements was issued on January 27, 2025.

What type of company is Inspira Technologies Oxy B.H.N. Ltd. based on its SIC code?

Inspira Technologies Oxy B.H.N. Ltd. is classified under SIC code 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

What is the filing number for this report?

The filing number for this report is 0001213900-25-006750.

Filing Stats: 311 words · 1 min read · ~1 pages · Grade level 9 · Accepted 2025-01-27 08:40:05

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: January 27, 2025 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing